FDA PMA FDA Class 2 Approved 🇺🇸 United States

Catheters, Transluminal Coronary Angioplasty, Percutaneous

PMA: P910031 · Supplement: S019 · Decision Dec 11, 1998
Classifications
1
FEI Numbers
70
Registration Numbers
70

Basic Information

Device Name
Catheters, Transluminal Coronary Angioplasty, Percutaneous
Trade Name
THE ORACLE MEGASONICS FIVE-64 PTCA CATHER
PMA Number
P910031
Supplement Number
S019
Device Class
FDA Class 2
Product Code
LOX
Generic Name
Catheters, transluminal coronary angioplasty, percutaneous
Regulation Number
870.5100
Medical Specialty
Cardiovascular
Advisory Committee
Cardiovascular
Decision
Approved
Decision Code
APPR
Decision Date
December 11, 1998
Date Received
June 15, 1998
Supplement Type
Normal 180 Day Track
Supplement Reason
Change Design/Components/Specifications/Material
Expedited Review
N

Advisory Committee Statement

Approval for modifications to the Endosonics Oracle MegaSonics Five-64(TM) PTCA Catheter.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
LOX Catheters, Transluminal Coronary Angioplasty, Percutaneous